FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA) - ES 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:500-600
Total Number of Projects:900-1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):900-1000
Partner Constancy:100-200
Project Leadership Index:80

Ranking timeline:

Project Participation Performance(2015-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 38
As coordinator: 5
As participant: 16
Sole participant: 17
Coordinator / Participant Ratio: 0.31*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 12.422.446 7.814.549 6.102.613 4 1
2021 5.568.037 22.057.315 3.253.716 4 2
2020 2.660.932 9.126.678 3.102.057 2 3
2019 150.000 11.939.458 856.530 1 2
2018 4.328.451 8.780.076 5.704.333 5 3
2017 316.243 0 316.243 2
2016 497.626 1.995.829 2.105.484 1 1
2015 3.261.158 27.564.353 3.356.065 3 4

Networking:

Partners:

Institution:Projects [No]:
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION8
EUROPEAN MOLECULAR BIOLOGY LABORATORY7
THE UNIVERSITY OF MANCHESTER5
CENTRE DE REGULACIO GENOMICA4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE4
KUNGLIGA TEKNISKA HOEGSKOLAN4
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
THE UNIVERSITY OF EDINBURGH3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ATOS ORIGIN INTEGRATION SAS2
CONSIGLIO NAZIONALE DELLE RICERCHE2
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN CANCER PATIENT COALITION2
FORSCHUNGSZENTRUM JULICH2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FUNDACIO CENTRE DE REGULACIO GENOMICA2
IAN HARROW CONSULTING2
INSTITUT CURIE2
INSTITUT PASTEUR2
KAROLINSKA INSTITUTE2
KLINIKUM DER UNIVERSITAET ZU KOELN2
MASARYKOVA UNIVERZITA2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
STICHTING DTL PROJECTS2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
STICHTING LYGATURE2
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET BASEL2
UNIVERSITAETSKLINIKUM HEIDELBERG2
UNIVERSITE DE LAUSANNE2
UNIVERSITE LIBRE DE BRUXELLES2
UNIVERSITEIT UTRECHT2
UNIVERSITY OF CAMBRIDGE2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF OSLO2
UNIVERZA V LJUBLJANI2
2CUREX1
AB ANALITICA1
ABO AKADEMI1
ACROSSLIMITS1
AIFORIA TECHNOLOGIES OYJ1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
ALIRA HEALTH SL1
ALTHAIA XARXA ASSISTENCIAL UNIVERSITARIA DE MANRESA FUNDACIO PRIVADA1
AMAZENTIS1
ARDIGEN1
ASTRAZENECA1
ATHINAEREVNITIKO KENTRO KAINOTOMIAS STIS TECHNOLOGIES TIS PLIROFORIAS TON EPIKOINONION KAI TIS GNOSIS1
BAYER1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRITISH COLUMBIA CANCER AGENCY BRANCH1
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LEDEVELOPPEMENT CIRAD EPIC1
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD1
CENTRO DE CIENCIAS DO MAR DO ALGARVE1
CESNET ZAJMOVE SDRUZENI PRAVNICKYCH OSOB1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY1
CHROMACURE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CSCTIETEEN TIETOTEKNIIKAN KESKUS OY1
DANISH CANCER SOCIETY1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EARLHAM INSTITUTE1
EATRIS ERIC1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELEM BIOTECH SL1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
ETAIRIA DIACHIRISIS KAI ANAPTIXIS EPISTIMONIKOU KAI TECHNOLOGIKOU PARKOU KRITIS AE1
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS1
EUROBIOIMAGING ERIC1
EUROPEAN ASSOCIATION FOR CANCER RESEARCH1
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM1
FOERDERVEREIN YOUNG ACADEMY OF EUROPE EV1
FONDAZIONE DEL PIEMONTE PER L'ONCOLOGIA1
FORSCHUNGSINSTITUT FUR MOLEKULARE PATHOLOGIE GESELLSCHAFT MBH1
FORWARD TECHNOLOGIES AB1
FUNDACAO CALOUSTE GULBENKIAN1
FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO INSTITUT DE CIENCIES FOTONIQUES1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM1
FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA1
FUNDACIO THE BARCELONA INSTITUTE OFSCIENCE AND TECHNOLOGY1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION CENTRO TECNOLOXICO DE TELECOMUNICACIONS DE GALICIA1
FUNDACION CIENTIFICA DE LA ASOCIACION ESPANOLA CONTRA EL CANCER1
FUNDACION DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRINCIPEFELIPE1
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD1
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD MP1
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III1

Constancy:

Total number of partners: 247
Partner loyalty:
Frequent Partner: (> 2 projects): 38
Rare Partner: 209
Frequent / Rare Partner Ratio: 0.18

Project overview:

Start dateProjectacronymrolefundingpartners
2022-11-01Data-driven cancer genome interpretation for personalised cancer treatment CGI-Clinicscoordinator9.257.50817
2022-09-01A European-wide foundation to accelerate Data-driven Cancer Research EOSC4Cancerparticipant7.814.54934
2022-09-01Detection and elimination of senescent cells targeting Cyclophilin D MitoSencoordinator165.3131
2022-07-01Origins and Consequences of Hematopoietic Stem Cell Memories MemOriStemcoordinator1.500.0001
2022-03-01Chemical rewiring of E3 ubiquitin ligases as a generalizable therapeutic approach TrickE3coordinator1.499.6251
2021-09-01IRB DoctoRal fEllowship ProgrAMme: attracting international talent (IRB_DREAM) IRB_DREAMcoordinator1.084.8001
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2021-05-01Novel senolytic drugs for the treatment of lung and kidney fibrosis SENFIBcoordinator150.0001
2021-03-01Deconstructing the evolution of metastasis Evometcoordinator4.014.43515
2021-02-01ENABLing CAReErS: priming talent for success in Biomedicine ENABLECAREScoordinator318.8035
2021-02-01Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer DECIDERparticipant14.999.33514
2020-10-01HPC/Exascale Centre of Excellence in Personalised Medicine - PerMedCoE PerMedCoEparticipant4.999.56814
2020-09-01MECHANISMS BEHIND RESIDUAL DISEASE IN COLORECTAL CANCER and MODELLING OF THERAPIES THAT PREVENT RELAPSE residualCRCcoordinator2.500.0001
2020-04-01Structural investigation of interplay between epigenetics, transcriptional regulation and DNA damage EPIDNAcoordinator160.9321
2020-04-01Rapid interaction profiling of 2019-nCoV for network-based deep drug-repurpose learning (DDRL) RiPCoNparticipant1.230.6353
2020-01-01The CALIPER project: Linking research and innovation for gender equality CALIPERparticipant2.896.47513
2019-05-01Joint Training and Research Program on Lifespan Regulation Mechanisms in Health and Disease HealthAgeparticipant3.940.62420
2019-01-01BioExcel Centre of Excellence for ComputationalBiomolecular Research BioExcel-2participant7.998.83414
2019-01-012shRNA branched nanobinders as promising therapeutic tools for combined cancer therapy 2shRNAcoordinator150.0001
2018-12-01Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity p38_InThcoordinator149.9371
2018-12-01Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing CRC-MTOscoordinator149.9551
2018-08-01Dietary Influences on Metastasis: How, When, and Why LIPOMETcoordinator2.370.6251
2018-04-01Iron as a driver of fibrosis and regeneration IRONAGEcoordinator158.1221
2018-02-01Hypermutated tumors: insight into genome maintenance and cancer vulnerabilities provided by an extreme burden of somatic mutations HYPER-INSIGHTcoordinator1.499.8131
2018-01-01Computational ONcology TRaining Alliance CONTRAparticipant3.863.97815
2018-01-01COFUND BIST PREDOCTORAL PROGRAMME PREBISTparticipant2.929.9206
2018-01-01Reticulate evolution: patterns and impacts of non-vertical inheritance in eukaryotic genomes. RETVOLUTIONparticipant1.986.1783
2017-09-01Dissecting gamma-TuRC composition and activity by Single Molecule Pull-down GTRcoordinator158.1221
2017-05-01FRAGMENT screening from advanced-sampling molecular dynamics simulations on a proteOME scale. FRAGMENTOMEcoordinator158.1221
2016-12-01Finding noncoding cancer drivers NONCODRIVERSparticipant1.995.8291
2016-07-01European Academy for Biomedical Science ENABLEcoordinator497.6265
2015-12-01Global BioImaging Project - International imaging infrastructure services for the life science community Global BioImagingparticipant1.780.5857
2015-11-01Multi-Scale Complex Genomics MuGcoordinator2.961.1636
2015-11-01Centre of Excellence for Biomolecular Research BioExcelparticipant4.782.28611
2015-10-01New breast cancer therapies based on available p38 MAPK inhibitors p38Curecoordinator149.9951
2015-09-01ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. ELIXIR-EXCELERATEparticipant19.051.48248
2015-07-01Description of information transfer across macromolecules by concerted conformational changes CONCERTparticipant1.950.0001
2015-03-01COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma COLOStagecoordinator150.0001